EKTAF
PINK Elekta AB Class B$5.36 ↓ -0.32 (-5.63%) Trading Down from the previous close of $5.68, and at the day’s high of $5.36
- YTD change
- -5.63%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.64 (-10.67%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 5.6% away from all-time highs of $5.68
- EKTAF is down 6% since the beginning of the year
- EKTAF is down 6% over the past 12 months
- EKTAF is down 6% over the past 1 month
- 2% of all EKTAF investors are betting against EKTAF
EKTAF reads n/a: the 12-month move is +3.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -5.63%
- vs 8-day SMA
- N/A
No alerts for EKTAF in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
Competitor comparison
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
